Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Novartis DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
The report details the trend, potential and market size of Renin-Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Renin-Inhibitorsmarket, defines the market attractiveness level of Renin-Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Renin-Inhibitors industry, describes the types of Renin-Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Renin-Inhibitors market and the development prospects and opportunities of Renin-Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Renin-Inhibitors market in Chapter 13.
By Player:
Noden Pharma
Novartis
By Type:
150mg/Tablet
300mg/Tablet
By End-User:
Age below 45
Age 45-55
Age 55-65
Age above 65
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Renin-Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Renin-Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Renin-Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Renin-Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Renin-Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Renin-Inhibitors Consumption (2017-2022)
-
7.2 United States Renin-Inhibitors Consumption (2017-2022)
-
7.3 Europe Renin-Inhibitors Consumption (2017-2022)
-
7.4 China Renin-Inhibitors Consumption (2017-2022)
-
7.5 Japan Renin-Inhibitors Consumption (2017-2022)
-
7.6 India Renin-Inhibitors Consumption (2017-2022)
-
7.7 South Korea Renin-Inhibitors Consumption (2017-2022)
8 Region and Country-wise Renin-Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Renin-Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Renin-Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Renin-Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Renin-Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Renin-Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Renin-Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Renin-Inhibitors Consumption Forecast (2022-2028)
9 Global Renin-Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Renin-Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 150mg/Tablet Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 300mg/Tablet Consumption and Growth Rate (2017-2022)
-
9.2 Global Renin-Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Age below 45 Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Age 45-55 Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Age 55-65 Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Age above 65 Consumption and Growth Rate (2017-2022)
10 Global Renin-Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Renin-Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 150mg/Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 300mg/Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Renin-Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Age below 45 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Age 45-55 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Age 55-65 Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Age above 65 Consumption Forecast and Growth Rate (2022-2028)
11 Global Renin-Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Renin-Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Renin-Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Renin-Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Renin-Inhibitors Market Competitive Analysis
-
14.1 Noden Pharma
-
14.1.1 Noden Pharma Company Details
-
14.1.2 Noden Pharma Renin-Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Noden Pharma Renin-Inhibitors Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Renin-Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Renin-Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Renin-Inhibitors
-
Figure Renin-Inhibitors Picture
-
Table Global Renin-Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Renin-Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Renin-Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Renin-Inhibitors Consumption by Country (2017-2022)
-
Figure United States Renin-Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Renin-Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Renin-Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Renin-Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Renin-Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Renin-Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Renin-Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Renin-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Renin-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Renin-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Renin-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Renin-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Renin-Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 150mg/Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global 300mg/Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Age below 45 Consumption and Growth Rate (2017-2022)
-
Figure Global Age 45-55 Consumption and Growth Rate (2017-2022)
-
Figure Global Age 55-65 Consumption and Growth Rate (2017-2022)
-
Figure Global Age above 65 Consumption and Growth Rate (2017-2022)
-
Figure Global 150mg/Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 300mg/Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Age below 45 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Age 45-55 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Age 55-65 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Age above 65 Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Renin-Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Renin-Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Noden Pharma (Foundation Year, Company Profile and etc.)
-
Table Noden Pharma Renin-Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Noden Pharma Renin-Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Renin-Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Renin-Inhibitors Product and Service
-
